Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Neutrophil Extracellular Traps (NETs) in the Cerebrospinal Fluid Samples from Children and Adults with Central Nervous System Infections.

Appelgren D, Enocsson H, Skogman BH, Nordberg M, Perander L, Nyman D, Nyberg C, Knopf J, Muñoz LE, Sjöwall C, Sjöwall J.

Cells. 2019 Dec 23;9(1). pii: E43. doi: 10.3390/cells9010043.

2.

Sex differences in clinical presentation of systemic lupus erythematosus.

Ramírez Sepúlveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jönsen A, Bengtsson C; DISSECT consortium, Nordmark G, Rantapää Dahlqvist S, Bengtsson AA, Rönnblom L, Sjöwall C, Gunnarsson I, Wahren-Herlenius M.

Biol Sex Differ. 2019 Dec 16;10(1):60. doi: 10.1186/s13293-019-0274-2.

3.

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus.

Reid S, Alexsson A, Frodlund M, Morris D, Sandling JK, Bolin K, Svenungsson E, Jönsen A, Bengtsson C, Gunnarsson I, Illescas Rodriguez V, Bengtsson A, Arve S, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Sjöwall C, Vyse TJ, Rönnblom L, Leonard D.

Ann Rheum Dis. 2019 Dec 11. pii: annrheumdis-2019-216227. doi: 10.1136/annrheumdis-2019-216227. [Epub ahead of print]

4.

[Hypocomplementemic urticarial vasculitis syndrome: a rare but not always benign condition].

Sjöwall C, Skattum L, Olsson M, Nilsson A, Mohammad AJ.

Lakartidningen. 2019 Nov 29;116. pii: FR49. Swedish.

5.

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.

Sohrabian A, Parodis I, Carlströmer-Berthén N, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I, Rönnelid J.

Arthritis Res Ther. 2019 Nov 29;21(1):259. doi: 10.1186/s13075-019-2056-y.

6.

Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.

Frodlund M, Wetterö J, Dahle C, Dahlström Ö, Skogh T, Rönnelid J, Sjöwall C.

Clin Exp Immunol. 2019 Nov 28. doi: 10.1111/cei.13402. [Epub ahead of print]

PMID:
31778219
7.

NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus.

Linge P, Arve S, Olsson LM, Leonard D, Sjöwall C, Frodlund M, Gunnarsson I, Svenungsson E, Tydén H, Jönsen A, Kahn R, Johansson Å, Rönnblom L, Holmdahl R, Bengtsson A.

Ann Rheum Dis. 2019 Nov 8. pii: annrheumdis-2019-215820. doi: 10.1136/annrheumdis-2019-215820. [Epub ahead of print]

PMID:
31704719
8.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2020 Jan;106:102340. doi: 10.1016/j.jaut.2019.102340. Epub 2019 Oct 17.

9.

Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives.

Svärd A, Roos Ljungberg K, Brink M, Martinsson K, Sjöwall C, Rantapää Dahlqvist S, Kastbom A.

Clin Exp Immunol. 2020 Feb;199(2):143-149. doi: 10.1111/cei.13381. Epub 2019 Oct 22.

10.

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.

Martinsson K, Roos Ljungberg K, Ziegelasch M, Cedergren J, Eriksson P, Klimovich V, Reckner Å, Griazeva I, Sjöwall C, Samoylovich M, Skogh T, Wetterö J, Kastbom A.

Rheumatology (Oxford). 2019 Aug 27. pii: kez348. doi: 10.1093/rheumatology/kez348. [Epub ahead of print]

PMID:
31504979
11.

Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.

Imgenberg-Kreuz J, Almlöf JC, Leonard D, Sjöwall C, Syvänen AC, Rönnblom L, Sandling JK, Nordmark G.

Front Immunol. 2019 Jul 30;10:1686. doi: 10.3389/fimmu.2019.01686. eCollection 2019.

12.

Low Production of Reactive Oxygen Species Drives Systemic Lupus Erythematosus.

Urbonaviciute V, Luo H, Sjöwall C, Bengtsson A, Holmdahl R.

Trends Mol Med. 2019 Oct;25(10):826-835. doi: 10.1016/j.molmed.2019.06.001. Epub 2019 Jul 11. Review.

PMID:
31303528
13.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

14.

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.

Frodlund M, Reid S, Wetterö J, Dahlström Ö, Sjöwall C, Leonard D.

Lupus. 2019 Sep;28(10):1261-1272. doi: 10.1177/0961203319860198. Epub 2019 Jul 11.

15.
16.

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus.

Eriksson P, Wallin P, Sjöwall C.

Front Pharmacol. 2019 Feb 6;10:82. doi: 10.3389/fphar.2019.00082. eCollection 2019.

17.

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Almlöf JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sjöwall C, Bengtsson AA, Jönsen A, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Hum Genet. 2019 Feb;138(2):141-150. doi: 10.1007/s00439-018-01966-7. Epub 2019 Feb 1.

18.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

19.

A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts.

Farias FHG, Dahlqvist J, Kozyrev SV, Leonard D, Wilbe M, Abramov SN, Alexsson A, Pielberg GR, Hansson-Hamlin H, Andersson G, Tandre K, Bengtsson AA, Sjöwall C, Svenungsson E, Gunnarsson I, Rantapää-Dahlqvist S, Syvänen AC, Sandling JK, Eloranta ML, Rönnblom L, Lindblad-Toh K.

Eur J Hum Genet. 2019 Mar;27(3):432-441. doi: 10.1038/s41431-018-0297-x. Epub 2018 Nov 20.

20.

Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.

Appelgren D, Dahle C, Knopf J, Bilyy R, Vovk V, Sundgren PC, Bengtsson AA, Wetterö J, Muñoz LE, Herrmann M, Höög A, Sjöwall C.

Autoimmunity. 2018 Sep;51(6):310-318. doi: 10.1080/08916934.2018.1514496. Epub 2018 Oct 28.

21.

Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.

Sjöwall C, Bentow C, Aure MA, Mahler M.

J Immunol Res. 2018 Aug 30;2018:1294680. doi: 10.1155/2018/1294680. eCollection 2018.

22.

Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.

Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12.

23.

Smoking reduces the efficacy of belimumab in mucocutaneous lupus.

Parodis I, Gomez A, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I.

Expert Opin Biol Ther. 2018 Aug;18(8):911-920. doi: 10.1080/14712598.2018.1494719. Epub 2018 Jul 9.

24.

The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination.

Mummert E, Fritzler MJ, Sjöwall C, Bentow C, Mahler M.

J Immunol Methods. 2018 Aug;459:11-19. doi: 10.1016/j.jim.2018.05.014. Epub 2018 May 26. Review.

PMID:
29807021
25.

Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis).

Sjöwall C, Mandl T, Skattum L, Olsson M, Mohammad AJ.

Rheumatology (Oxford). 2018 Aug 1;57(8):1400-1407. doi: 10.1093/rheumatology/key110.

PMID:
29718374
26.

Uptake of rheumatology biosimilars in the absence of forced switching.

Di Giuseppe D, Frisell T, Ernestam S, Forsblad-D'Elia H, Lindqvist E, Lindström U, Sjöwall C, Askling J; ARTIS group.

Expert Opin Biol Ther. 2018 May;18(5):499-504. doi: 10.1080/14712598.2018.1458089. Epub 2018 Apr 10.

27.

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.

Leonard D, Svenungsson E, Dahlqvist J, Alexsson A, Ärlestig L, Taylor KE, Sandling JK, Bengtsson C, Frodlund M, Jönsen A, Eketjäll S, Jensen-Urstad K, Gunnarsson I, Sjöwall C, Bengtsson AA, Eloranta ML, Syvänen AC, Rantapää-Dahlqvist S, Criswell LA, Rönnblom L.

Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.

28.

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Padyukov L, Gunnarsson I, Svenungsson E, Sjöwall C, Rönnblom L, Syvänen AC, Sandling JK.

Ann Rheum Dis. 2018 May;77(5):736-743. doi: 10.1136/annrheumdis-2017-212379. Epub 2018 Feb 1.

29.

Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE.

Wirestam L, Frodlund M, Enocsson H, Skogh T, Wetterö J, Sjöwall C.

Lupus Sci Med. 2017 Jul 28;4(1):e000225. doi: 10.1136/lupus-2017-000225. eCollection 2017.

30.

Response to: 'Increased stroke incidence in systemic lupus erythematosus patients: risk factors or disease itself?' by Bruzzese and Zullo.

Arkema EV, Rossides M, Von Euler M, Svenungsson E, Sjöwall C, Simard JF.

Ann Rheum Dis. 2018 Oct;77(10):e72. doi: 10.1136/annrheumdis-2017-212604. Epub 2017 Nov 16. No abstract available.

PMID:
29146744
31.

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

Almlöf JC, Alexsson A, Imgenberg-Kreuz J, Sylwan L, Bäcklin C, Leonard D, Nordmark G, Tandre K, Eloranta ML, Padyukov L, Bengtsson C, Jönsen A, Dahlqvist SR, Sjöwall C, Bengtsson AA, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Sci Rep. 2017 Jul 24;7(1):6236. doi: 10.1038/s41598-017-06516-1.

32.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

33.

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson AA, Holmdahl R.

Ann Rheum Dis. 2017 Sep;76(9):1607-1613. doi: 10.1136/annrheumdis-2017-211287. Epub 2017 Jun 12.

PMID:
28606963
34.

Editorial: The Effect of Ethnicity on Cardiovascular Outcomes in Systemic Lupus Erythematosus Is Perhaps Not a Paradox.

Pope JE, Weisman MH, Sjöwall C.

Arthritis Rheumatol. 2017 Sep;69(9):1707-1709. doi: 10.1002/art.40173. No abstract available.

35.

Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.

Stümer J, Biermann MHC, Knopf J, Magorivska I, Kastbom A, Svärd A, Janko C, Bilyy R, Schett G, Sjöwall C, Herrmann M, Muñoz LE.

Clin Exp Immunol. 2017 Sep;189(3):372-382. doi: 10.1111/cei.12987. Epub 2017 Jun 13.

36.

Stroke in systemic lupus erythematosus: a Swedish population-based cohort study.

Arkema EV, Svenungsson E, Von Euler M, Sjöwall C, Simard JF.

Ann Rheum Dis. 2017 Sep;76(9):1544-1549. doi: 10.1136/annrheumdis-2016-210973. Epub 2017 Apr 11.

37.

Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.

Clin Exp Immunol. 2017 Jul;189(1):83-91. doi: 10.1111/cei.12957. Epub 2017 Mar 31.

38.

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.

Parodis I, Sjöwall C, Jönsen A, Ramsköld D, Zickert A, Frodlund M, Sohrabian A, Arnaud L, Rönnelid J, Malmström V, Bengtsson AA, Gunnarsson I.

Autoimmun Rev. 2017 Apr;16(4):343-351. doi: 10.1016/j.autrev.2017.02.005. Epub 2017 Feb 13. Review.

PMID:
28216072
39.

Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases.

Sjöwall C, Hjorth M, Eriksson P.

Lupus. 2017 Oct;26(12):1333-1338. doi: 10.1177/0961203317691371. Epub 2017 Feb 5.

40.

Cervical neoplasia in systemic lupus erythematosus: a nationwide study.

Wadström H, Arkema EV, Sjöwall C, Askling J, Simard JF.

Rheumatology (Oxford). 2017 Apr 1;56(4):613-619. doi: 10.1093/rheumatology/kew459.

41.

Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.

Ziegelasch M, van Delft MA, Wallin P, Skogh T, Magro-Checa C, Steup-Beekman GM, Trouw LA, Kastbom A, Sjöwall C.

Arthritis Res Ther. 2016 Dec 3;18(1):289.

42.

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis.

Dieker J, Berden JH, Bakker M, Briand JP, Muller S, Voll R, Sjöwall C, Herrmann M, Hilbrands LB, van der Vlag J.

PLoS One. 2016 Oct 25;11(10):e0165373. doi: 10.1371/journal.pone.0165373. eCollection 2016.

43.

Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.

Hellberg S, Eklund D, Gawel DR, Köpsén M, Zhang H, Nestor CE, Kockum I, Olsson T, Skogh T, Kastbom A, Sjöwall C, Vrethem M, Håkansson I, Benson M, Jenmalm MC, Gustafsson M, Ernerudh J.

Cell Rep. 2016 Sep 13;16(11):2928-2939. doi: 10.1016/j.celrep.2016.08.036.

44.

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population-Based Study of Maternal and Fetal Outcomes in SLE and Pre-SLE.

Arkema EV, Palmsten K, Sjöwall C, Svenungsson E, Salmon JE, Simard JF.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):988-94. doi: 10.1002/acr.22791.

45.

Long-term outcomes of destructive seronegative (rheumatoid) arthritis - description of four clinical cases.

Nikiphorou E, Sjöwall C, Hannonen P, Rannio T, Sokka T.

BMC Musculoskelet Disord. 2016 Jun 3;17:246. doi: 10.1186/s12891-016-1067-y.

46.

International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.

Bentow C, Lakos G, Martis P, Wahl E, Garcia M, Viñas O, Espinosa G, Cervera R, Sjöwall C, Carmona-Fernandes D, Santos MJ, Hanly JG, Mahler M.

Lupus. 2016 Jul;25(8):864-72. doi: 10.1177/0961203316640917.

PMID:
27252263
47.

Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.

Crisci E, Ellegård R, Nyström S, Rondahl E, Serrander L, Bergström T, Sjöwall C, Eriksson K, Larsson M.

J Virol. 2016 Apr 29;90(10):4939-4950. doi: 10.1128/JVI.00224-16. Print 2016 May 15.

48.

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.

Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää-Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.

Semin Arthritis Rheum. 2016 Jun;45(6):684-90. doi: 10.1016/j.semarthrit.2015.11.013. Epub 2015 Dec 2.

PMID:
26743074
49.

Case definitions in Swedish register data to identify systemic lupus erythematosus.

Arkema EV, Jönsen A, Rönnblom L, Svenungsson E, Sjöwall C, Simard JF.

BMJ Open. 2016 Jan 4;6(1):e007769. doi: 10.1136/bmjopen-2015-007769.

50.

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, Wetterö J, Sjöwall C.

Arthritis Res Ther. 2015 Nov 23;17:338. doi: 10.1186/s13075-015-0856-2.

Supplemental Content

Loading ...
Support Center